SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C.  20549
--------------------------------------------------------------------------------

                                   FORM 10-QSB
(Mark  One)
/ X /     ANNUAL  REPORT  UNDER  SECTION  13  OR  15(d)  OF  THE  SECURITIES
          EXCHANGE  ACT  OF  1934
For  the  quarter  ended  June  30,  2000

                                       OR

/   /     TRANSITION  REPORT  UNDER  SECTION  13  OR  15(d)  OF  THE  SECURITIES
          EXCHANGE  ACT  OF  1934
For  the  transition  period  from            to
                                    --------      ---------

                     Commission file number     33-96882-LA
                                                -----------

                       CARING PRODUCTS INTERNATIONAL, INC.
                 (Name of small business issuer in its charter)
                              --------------------

         DELAWARE                                         98-0134875
(State or other jurisdiction of                (IRS Employer Identification No.)
 incorporation or organization)

                              --------------------

                     PO BOX 9288,  SEATTLE, WASHINGTON 98109
                           (principal mailing address)

                                 (206) 523-7065
                (Issuer's telephone number, including area code)
                              --------------------

     Securities  registered  under Section 12(b) of the Exchange Act:  None.

     Securities  registered  under  Section  12(g)  of  the  Exchange  Act:
          Common  Stock,  $.01  par  value
          Warrants  to  purchase  common  stock.

Check  whether  the  issuer:     (1)  filed  all reports required to be filed by
Section  13 or 15 (d) of the Exchange Act during the past 12 months (or for such
shorter  period  that the registrant was required to file such reports), and (2)
has  been  subject  to  such  filing  requirements  for  the  past  90  days.
Yes  X     No
    ---

Check  if there is no disclosure of delinquent filers in response to Item 405 of
Regulation  S-B  contained in this form, and no disclosure will be contained, to
the  best  of  registrant's  knowledge,  in  definitive  proxy  or  information
statements  incorporated  by  reference  in Part III of this Form 10-QSB.  / X /

                   ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS
                           DURING THE PAST FIVE YEARS
     Not applicable.
                       APPLICABLE ONLY TO CORPORATE REGISTRANTS

     State  the  number of shares outstanding of each of the issuer's classes of
common  equity, as of  July 21, 2000: 3,056,343 shares of common stock, $.01 par
value  (the  "Common  Stock").

     Transitional  Small  Business  Disclosure  Format  (check  one):
Yes   No  X
                       DOCUMENTS INCORPORATED BY REFERENCE

Part III - Certain exhibits                    Included in prior filings made
Listed in response to Item 13(a)               under the Securities Act of 1933.


1
<PAGE>
                       CARING PRODUCTS INTERNATIONAL, INC
                                   FORM 10-QSB
                       FOR THE PERIOD ENDED JUNE 30, 2000


     INDEX                                                           PAGE NUMBER


PART  I     FINANCIAL  INFORMATION


Financial  Statements

  Item 1 Financial Statements


         Consolidated Balance Sheets at March 31, 2000 and June 30, 2000       3
               (unaudited  for  June  30,  2000  period)

         Consolidated Statements of Operations for each of the three-month     4
         periods  ended  June  30,  1999  and  June  30,  2000
               (unaudited)

         Consolidated Statements of Cash Flows  for  the three-month           5
         periods  ended  June  30,  1999  and  June  30,  2000
               (unaudited)

         Notes to Consolidated Financial Statements                            6


  Item 2 Managements  Discussion  and  Analysis  of
          Financial  Condition  and  Results  of  Operations                   7


PART II  OTHER  INFORMATION                                                    9


2
<PAGE>
<TABLE>
<CAPTION>
              CARING PRODUCTS INTERNATIONAL, INC. AND SUBSIDIARIES
                            CONSOLIDATED BALANCE SHEETS


                                        ASSETS
                                                                             JUNE 30
                                                             MARCH 31         2000
                                                               2000        (UNAUDITED)
                                                           -------------  -------------
<S>                                                        <C>            <C>
Current Assets
  Cash                                                     $    181,763   $    104,845
  Accounts receivable less allowance
     of $3,026 at March 31, 2000 and June 30, 2000               57,498         21,744
  Inventories                                                    15,715         11,101
  Prepaid expenses                                               24,091          7,168
                                                           -------------  -------------

          Total current assets                                  279,067        144,858

  Equipment, net                                                 20,338         15,484
                                                           -------------  -------------

                                                           $    299,405   $    160,342
                                                           =============  =============

                        LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities
  Accounts payable                                         $    107,945   $     86,234
  Accrued liabilities                                            24,621         15,156
  Customer Sales Account Deposit                                      -         32,339
                                                           -------------  -------------

          Total current liabilities                             132,566        133,729
Stockholders' equity
  Preferred stock, par value $0.01 per share; authorized,
    1,000,000 shares; none outstanding                                -              -
  Common stock, par value $0.01 per share; authorized,
    15,000,000 shares; issued and outstanding, 3,056,343
    in March 31, 2000 and June 30, 2000, respectively            30,564         30,564
  Additional paid-in capital                                 19,232,069     19,232,069
  Accumulated deficit                                       (19,095,794)   (19,236,020)
                                                           -------------  -------------

          Total stockholders' equity                            166,839         26,613
                                                           -------------  -------------

                                                           $    299,405   $    160,342
                                                           =============  =============


3
<PAGE>
              CARING PRODUCTS INTERNATIONAL, INC. AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                 THREE MONTH PERIODS ENDED JUNE 30, 1999 AND 2000
                                     (UNAUDITED)


                                                              JUNE 30         JUNE 30
                                                                1999           2000
                                                            -------------  -------------

Revenues                                                    $    154,035   $     36,250
Cost of sales                                                     47,955          4,614
                                                            -------------  -------------

        Gross profit                                             106,080         31,636

Operating expenses
  Selling                                                         12,787         17,431
  General and administrative                                     412,393        156,982
  Amortization and depreciation                                   23,695          4,854
                                                            -------------  -------------

        Total operating expenses                                 448,875        179,267
                                                            -------------  -------------

        Loss from operations                                    (342,795)      (147,631)

Other income (expense)
  Other income                                                    11,664          7,405
  Interest expense                                                  (741)             -
  Loss on sale of assets                                         (84,176)             -
                                                            -------------  -------------

                                                                 (73,253)         7,405
                                                            -------------  -------------

        Net loss                                            $   (416,048)  $   (140,226)
                                                            =============  =============


  Weighted average common shares outstanding                   3,056,343      3,056,343
                                                            =============  =============

  Net loss per common share                                 $      (0.14)  $      (0.05)
                                                            =============  =============


4
<PAGE>
              CARING PRODUCTS INTERNATIONAL, INC. AND SUBSIDIARIES
                     CONSOLIDATED STATEMENTS OF CASH FLOWS
                 THREE MONTH PERIODS ENDED JUNE 30, 1999 AND 2000
                                     (UNAUDITED)

                                                              JUNE 30         JUNE 30
Increase (Decrease) in Cash                                     1999           2000
                                                            -------------  -------------

Cash flows from operating activities
  Net loss                                                  $   (416,048)  $   (140,226)
  Adjustments to reconcile net loss to net cash
    used in operating activities
    Amortization and depreciation                                 23,695          4,854
    Issuance of restricted common stock to employees              55,000              -
    Loss from disposal of equipment                               84,176              -
    Changes in operating assets and liabilities
      Customer sales account deposit                            (174,694)        32,339
      Accounts receivable                                        209,115         35,754
      Inventories                                                225,139          4,614
      Prepaid expenses                                                 -         16,923
      Other assets                                                (8,877)             -
      Accounts payable                                           (77,190)       (21,711)
      Accrued liabilities                                         (1,475)        (9,465)
                                                            -------------  -------------
        Net cash used in operating activities                    (81,159)       (76,918)

Cash flows from investing activities
  Proceeds from sale of equipment                                  1,351              -
                                                            -------------  -------------
        Net cash provided by investing activities                  1,351              -

Decrease in cash                                                 (79,808)       (76,918)

Cash at beginning of period                                      707,847        181,763
                                                            -------------  -------------

Cash at end of period                                       $    628,039   $    104,845
                                                            =============  =============

Supplemental cash flow information:
  Cash paid for interest                                    $        741   $          -
                                                            =============  =============

Noncash investing and financing activities:
  Net book value of assets spun off to Creative Products    $    151,866   $          -
                                                            =============  =============
</TABLE>


5
<PAGE>
                       CARING PRODUCTS INTERNATIONAL, INC.
                                AND SUBSIDIARIES
              NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
            THREE MONTH PERIOD ENDED JUNE 30, 1999 AND JUNE 30, 2000



NOTE  1  -  FINANCIAL  STATEMENTS

     The  unaudited  consolidated  financial  statements  and related  notes are
     presented  as  permitted  by  Form  10-QSB  and  do  not  contain   certain
     information  included  in  the  Company's  audited  consolidated  financial
     statements  and  notes for the  fiscal  year  ended  March  31,  2000.  The
     information  furnished  reflects,   in  the  opinion  of  management,   all
     adjustments,  consisting of normal recurring accruals, necessary for a fair
     presentation of the results of the interim periods  presented.  The results
     of operation for the interim periods are not necessarily  indicative of the
     results to be expected  for the entire  fiscal year ending  March 31, 2001.
     The accompanying  unaudited  consolidated  financial statements and related
     notes should be read in conjunction with the audited consolidated financial
     statements and the Form 10-KSB of Caring Products  International,  Inc. and
     its  subsidiaries  (the  "Company") and notes thereto,  for its fiscal year
     ended March 31, 2000.

NOTE  2  -  LOSS  PER  COMMON  SHARE

     The Company accounts for loss per common share under Statement of Financial
     Accounting  Standards  No  128,  "Earnings  Per  Share"  which  established
     standards for computing and presenting  earnings per share.  Loss per share
     is based on the weighted average number of common shares outstanding during
     each  period and income  available  to common  stockholders.  The  weighted
     average  number of common  shares was 3,056,343 for the three month periods
     ended June 30,  1999 and June 30,  2000.  The  effect of common  equivalent
     shares on the computation of loss per share assuming dilution for the three
     months  ended  June  30,  1999 and June  30,  2000  was  anti-dilutive  and
     therefore is not included.

NOTE  3  -  INVENTORIES

     Inventories  consisted  of  finished  goods and are  stated at the lower of
     cost,  as  determined by the  first-in,  first-out  method,  or market (net
     realizable  value).  At the end of Fiscal Year 2000, the Company wrote down
     $166,153 of  inventory to account for certain  products  that were held for
     more than a 12 month period,  products  specifically  packaged for a retail
     chain or a specific market in which the Company's products are no longer in
     active  distribution,  to  reflect  reduced  sales  activity  from  lack of
     advertising  and the  expectation  that the Company  will have to sell such
     inventory at substantial  discounts or dispose through charitable donations
     to  hospitals  or  relief  organizations.  The  Company  closed  one of its
     fulfillment  centers  on or about June 30,  2000 and may close more  during
     Fiscal 2001 due to declining  need for  inventory  storage and  fulfillment
     services.

NOTE  4  -  POST  PERIOD  EVENT

     On July 3, 2000,  the  Company  signed  a  non-binding  letter of intent to
     merge with a digital imaging product company.  The merger is subject to due
     diligence,  execution  of  definitive agreements and shareholder  approval.
     The  agreement  provides  for the Company to issue approximately 30 million
     shares of common stock as part of the proposed transaction upon closing.

NOTE  5  -  GOING  CONCERN

     The Company  incurred a net loss of  $416,048  and  $140,226  for the three
     months ended June 30, 1999 and 2000, respectively. The Company's ability to
     continue  as a going  concern is  contingent  upon its  ability to maintain
     positive cash flow from  operating and  financing  activities.  The Company
     continues to review all its strategic options.


6
<PAGE>
     ITEM 2.     MANAGEMENT'S DISCUSSION AND  ANALYSIS  OR  PLAN  OF  OPERATION.

THE  FOLLOWING  ANALYSIS OF THE RESULTS OF OPERATIONS AND FINANCIAL CONDITION OF
THE  COMPANY  SHOULD  BE  READ  IN  CONJUNCTION  WITH THE CONSOLIDATED FINANCIAL
STATEMENTS,  INCLUDING  THE NOTES THERETO, OF THE COMPANY CONTAINED ELSEWHERE IN
THIS  FORM  10-QSB.


OVERVIEW

Caring  Products  International  Inc  and  its  subsidiaries  (collectively  the
"Company" or "CPI") has designed a line of proprietary urinary incontinence pant
and  liner  products  which  have  been  sold  under  the  Rejoice  trade  name.
Historically,  the  Company's  customer  base  has been retail drug stores, home
healthcare  companies,  surgical  supply  stores  and  national  drug  wholesale
companies.  Given  the  high  costs  associated  with increasing and maintaining
distribution  for  its incontinence products at larger retail drug chain stores,
increased  competition,  and  executive  management  changes, in early 1999, the
Company  announced its intent to evaluate all of its strategic options including
licensing  the  Company's  products,  merging  with  another  company, potential
acquisitions,  obtaining  new  sources  of equity and cost-cutting measures.  As
part of the Company's cost cutting measures, the Company ceased paid advertising
to  consumers  and participation in costly in-store chain promotions which are a
requirement  to remain on the shelves of many large drug store chains in the US.
The  Company  further  reduced  its  payroll  and  other  administrative  costs.

As  part  of  the  Company's  restructuring  efforts,  on December 23, 1999, the
Company  spun-off  its  wholly-owned  subsidiary Creative Products International
Inc.  to  shareholders  of  record  on  June  30,  1999.

During  the  quarter  ended  June  30,  2000,  the  Company's sales continued to
decline.  While  the  Company  has  significantly  reduced  expenditures  in all
aspects  of  the  Company's operations, it expects that it will continue to lose
money.   The  Company  closed  one  if  its product fulfillment centers and will
begin  to  close more of its fulfillment centers on or about June 30, 2000.  The
Company  is  not  under contractual obligation and may close any facility at any
time,  without  ongoing  expense  to  the  Company.

On  July  3, 2000, the  Company  signed  a non-binding letter of intent to merge
with a digital imaging products company.  This  merger  is  subject to final due
diligence, execution  of definitive agreements and shareholder approval.

RESULTS  OF  OPERATIONS  AND  OPERATING  EXPENSES

Revenues  decreased  from  $154,035  in  the  1999 Period to $36,250 in the 2000
Period,  a 77% decrease.  The decrease was a result of declining distribution of
Rejoice  in  drug  stores,  discontinued  support  of  the  brand  in  consumer
advertising,  increased  problems for long-term consumers to find a local source
of  supply  for the brand, and lack of available products sold in the quantities
and  styles  desired  by  national distributors of consumer healthcare products.

Cost  of sales decreased from $47,955 for the 1999 Period to  $4,614 in the 2000
Period,  a  decrease  of  90%.  This  decrease  is  primarily  attributable  to
reductions  in  sales  and sale of certain inventory which had been written down
during  the  Fiscal  Year  ended  March 31, 2000. The Company did not add to its
inventory  through  new  production  during  the  period.

For  the  quarter ended 2000, the Company generated a gross profit of $31,636 as
compared  to  a  gross  profit  of  $106,080  in the June 30, 1999 Period, a 70%
reduction.  This  reduction in gross profit reflected the comparable decrease in
sales.

Total  operating  expenses decreased from $448,875 in the June 30 1999 Period to
$179,267  in  the  June 30, 2000 Period, a 60% decrease.  This decrease reflects
the  implementation  of  the  Company's  cost  cutting  programs  which included
reductions  in payroll, sales and advertising, product storage and distribution,
customer  service  and  other  administration associated with serving a national
consumer  base  which  purchases products through chain drug stores to a smaller
consumer  base  which  purchases  products  through  direct mail,  regional drug
stores  and  catalogs.  Selling  costs  increased  36%  from $12,787 in the 1999
Period to $17,431 in the 2000 Period due to the increasing cost of warehouse and
storage  and  shipping  expenses  and  inability  of  the  Company  to negotiate
volume-oriented  vendor  discount  agreements.


7
<PAGE>
General  and  administrative  expenses  decreased  62% from $412,393 in the 1999
Period  to $156,982 in the 2000 Period.   Accounting and legal fees continued to
be  a  significant  portion  of  administration  costs  due  to specific filing,
accounting and negotiation of the proposed merger. Depreciation and amortization
expense  decreased from $23,695 in the 1999 Period to $4,854 in the 2000 Period,
an  80%  decrease.  The  decrease  is  primarily attributable to the transfer of
assets to Creative Products International Inc which was subsequently spun-off to
shareholders  as  a separate operating company and reduction of value of certain
equipment.

Interest  expense  decreased  from $741 in 1999 to $0 in 2000. This decrease was
attributable  to  the  elimination  of  short-term  obligations.  Other  income
generated was $7,405 in the 2000 Period compared to $11,664 in Fiscal 1999. This
decrease  was  attributable  to  reduction  in cash balances in interest bearing
deposits.

As  a  result of the foregoing, the Company generated a loss of $416,048 for the
1999  Period  as  compared  to a net loss of $140,226 for the 2000 Period, a 66%
reduction.  For  the  three  months  ended  June  30,  2000 the number of shares
outstanding  remained  at  3,056,343.

LIQUIDITY  AND  CAPITAL  RESOURCES

The  Company has historically financed its operations through the sale of equity
and  debt.  As  of  June  30,  2000,  the  Company  did not generate new funding
through  the  sale  of  securities, exercise of stock options or warrants or new
debt  to  the  Company.

As  of  June 30, 2000 the Company's principal sources of liquidity included cash
of  $104,845,  net  accounts  receivable of $21,744 after allowance for doubtful
accounts  of  $3,026  and  inventory  of $11,101.  At the end of the Period, the
Company  received  a $32,339 deposit from a customer as payment for the shipment
of  various incontinence products.  This order was subsequently shipped in early
July.  The  cost  of  goods  related  to  this  order  was approximately $1,200.

The  Company's  operating activities used cash of $76,918 in the 2000 Period and
$81,159  in  the 1999 Period.   The Company's future liquidity will be dependent
on  the  Company's  ability  to continue to sell its remaining inventory, reduce
expenses, close its warehouses as planned, collect its receivables, complete its
proposed  merger  on  a  timely  basis, or obtain new sources of debt or equity.
There is no assurance that the Company will be able to generate the funds needed
to  offset  its  current  or  future  obligations  on  a  timely  basis.

FORWARD  LOOKING  STATEMENTS

This Form 10-QSB and other reports and statements filed by the Company from time
to time with the Securities and Exchange Commission (collectively the "Filings")
contain or may contain forward-looking statements and information that are based
upon  beliefs  of,  and  information  currently  available  to,  the  Company's
management,  as  well  as  estimates  and  assumptions  made  by  the  Company's
management.

When  used  in  the  Filings,  the  words  "anticipate",  "believe", "estimate",
"expect",  "future", "intend", "plan" and similar expressions, as they relate to
the  Company  or  the Company's management, identify forward-looking statements.
Such  statements  reflect the current view of the Company with respect to future
events  and  are subject to risks, uncertainties and assumptions relating to the
Company's  operations and results of operations, competitive factors and pricing
pressures,  shifts in market demand, the performance and needs of the industries
which  constitute the customers of the Company, the costs of product development
and  other  risks and uncertainties, including, in addition to any uncertainties
with  respect  to  management  of  growth,  increases  in sales, the competitive
environment,  hiring  and  retention  of  employees,  pricing,  new  product
introductions,  product  productivity,  distribution  channels,  enforcement  of
intellectual  property  rights,  possible  volatility of stock price and general
industry  growth  and economic conditions.  Should one or more of these risks or
uncertainties materialize, or should the underlying assumptions prove incorrect,
actual  results  may  differ  significantly  from  those  anticipated, believed,
estimated,  expected,  intended  or  planned.


8
<PAGE>
PART  I:         FINANCIAL  INFORMATION


Item  1          Legal  Proceedings.

                 None.

Item  2          Changes  in  Securities.

                 None.

Item  3          Defaults  Upon  Senior  Securities.

                 None.

Item  4          Submission  of  Matters  to  a  Vote  of  Security  Holders

                 None.

Item  5          Other  Information.

                 None.

Item  6          Exhibits

                 27.1  --  Financial  Data  Schedule


                                   SIGNATURES


In  accordance  with  the  requirements of Section 13 or 15(d) of the Securities
Exchange  Act  of  1934,  the  registrant caused this report to be signed on its
behalf  by  the  undersigned, thereunto duly authorized, in the City of Seattle,
Washington,  on  August 4,  2000.


                              CARING  PRODUCTS  INTERNATIONAL,  INC.

                              By:  /s/  Susan  A.  Schreter
                                   ---------------------------------
                                        Susan  A.  Schreter
                                        Acting Chairman of the Board and
                                        CEO


In  accordance  with  the requirements of the Exchange Act, this report has been
signed  by  the  following  persons  on  behalf  of  the  registrant  and in the
capacities  and  on  the  dates  indicated:

     SIGNATURE                          TITLE                     DATE
     ---------                          -----                     ----
/s/ Susan A. Schreter           Acting Chairman and CEO       August 4, 2000
--------------------------
Susan  A.  Schreter


9
<PAGE>